Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The first-ever vaccine against the common sexually transmitted infection appears safe and active.
Previously, tests were approved only for use with genital or urine samples.
The World Health Organization revises its therapy guidelines for chlamydia, gonorrhea and syphilis, which adapt to thwart current meds.
U.S. syphilis rate is continuing its steady climb, with men who have sex with men (MSM) driving a 10 percent increase between 2012 and 2013.
Prophylactics don’t stop all sexually transmitted infections.
In today’s society, it appears it is just fine to absolve yourself of any accountability. Instead, ask your local politicians to draft up a la...
Latex condoms need to be used both consistently and correctly to reduce the risk of becoming infected with some common non-viral sexually tran...
Researchers found that 11 percent of participants had acquired gonorrhea or chlamydia and that the risk was significantly greater in young, Af...
Health care workers test more young African-American and Hispanic women for chlamydia than white women. And this may inflate reported rates of...
Girls ages 15 to 19 accounted for nearly 410,000 of the 1.5 million chlamydia and gonorrhea case.
When was your last screening?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.